echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > BJH: Persistent fatigue symptoms, neuropathy, and role dysfunction in survivors of indolent non-Hodgkin lymphoma: a longitudinal PROFILES registry study

    BJH: Persistent fatigue symptoms, neuropathy, and role dysfunction in survivors of indolent non-Hodgkin lymphoma: a longitudinal PROFILES registry study

    • Last Update: 2022-05-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Little is known about long-term health-related quality of life (HRQoL) and symptom persistence in patients with indolent non-Hodgkin lymphoma (iNHL) .


    Little is known about long-term health-related quality of life (HRQoL) and symptom persistence in patients with indolent non-Hodgkin lymphoma (iNHL) .


    Figure 1: Flow chart of the data acquisition process


    Figure 1: Flow chart of the data acquisition process


    The study included longitudinal surveys of patients diagnosed between 1999 and 2014 and four or more months after diagnosis


    Table 1: Patient characteristics by cancer type or normal population mean (SD) or N (%)

    Table 1: Patient characteristics by cancer type or normal population mean (SD) or N (%) Table 1: Patient characteristics by cancer type or normal population mean (SD) or N (%)

    Initial treatment was active surveillance (52%), systemic therapy (31%), or radiotherapy (13%)


    Initial treatment was active surveillance (52%), systemic therapy (31%), or radiotherapy (13%)


    Figure 2: (A) Fatigue; (B) Neuropathy; and (C) Role Function 10 years after diagnosis


    Figure 2: (A) Fatigue; (B) Neuropathy; and (C) Role Function 10 years after diagnosis


    Figure 3: Percentage of patients with persistent fatigue, neuropathy, and role dysfunction compared to the normal population


    Figure 3: Percentage of patients with persistent fatigue, neuropathy, and role dysfunction compared to the normal population


    Scores remained relatively stable with no clinically relevant changes for up to 10 years after diagnosis


     

    Original source:

    Original source:

    Ekels, A ,van de Poll-Franse, LV ,Posthuma, EFM ,Kieffer, J ,Issa, DE ,  Koster, A , et al.


    Ekels, A ,  van de Poll-Franse, LV ,  Posthuma, EFM ,  Kieffer, J ,  Issa, DE ,  Koster, A , et al.
      Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study .
      Br J Haematol .
      2022 ;  00 :  1–12 .
    https://doi.
    org/10.
    1111/bjh.
    18139 Ekels , A ,  van  de Poll-Franse, LV ,  Posthuma, EFM ,  Kieffer, J ,  Issa, DE ,  Koster, A, et al.
      Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study .
    Br  J Haematol .
      2022 ;  00 :  1–12.
    https :  //doi.
    org/10.
    1111 /bjh.
    18139 Ekels, A van de Poll-Franse, LV Posthuma, EFM Kieffer, J Issa, DE Koster, A Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study Br J Haematol 2022 00 1 12

    Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.